Subscribe
type here...
Subscribe

Tag: COVID-19 vaccine

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Global Markets Pharma -
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Pharma -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

Moderna to build a new vaccine plant in the UK

Manufacturing Pharma -
U.S. biotech firm Moderna  will build a new research and manufacturing centre in Britain to develop vaccines against new...

Moderna invests 500 million euros in Spain to boost vaccine production

News Pharma -
Moderna plans to invest around 500 million euros ($520.60 million) in a new laboratory in Spain to boost its...

Valneva stocks fall as European deal on COVID vaccine flounders

Global Markets Pharma -
Valneva shed around a quarter of its market value on Monday after the French drugmaker warned that the future...

Moderna fell, Novavax rose – positive vaccine news caused mixed reactions

Global Markets Pharma -
Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies...

Novavax’s COVID-19 vaccine received FDA AdCom approval, clearing “serious hurdles”

Global Markets Pharma -
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the...

Moderna’s delivery of COVID-19 booster doses to EU is postponed, shares drop

Global Markets Pharma -
Shares of Moderna are trading 2% lower Thursday morning as the company announced it had agreed to amend the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Regulatory Pharma -
Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

EAEU Market Pharma -
Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization...

Valneva shares drop 20% after deal with EU on COVID vaccine is broken

Global Markets Pharma -
Shares of Valneva plunged 20% on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European...

FDA restricts J&J’s COVID-19 vaccine on blood clot risks

Regulatory Pharma -
The Food and Drug Administration is limiting the use of the J&J shot, which received U.S. clearance in February...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026